TRIM29
Basic information
Region (hg38): 11:120111286-120185529
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TRIM29 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 70 | 70 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 70 | 0 | 1 |
Variants in TRIM29
This is a list of pathogenic ClinVar variants found in the TRIM29 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-120112422-C-T | not specified | Uncertain significance (Dec 26, 2023) | ||
11-120112431-A-C | not specified | Uncertain significance (Jan 17, 2024) | ||
11-120112440-C-T | not specified | Uncertain significance (Aug 12, 2021) | ||
11-120112467-G-A | not specified | Uncertain significance (Feb 24, 2025) | ||
11-120112473-G-C | not specified | Uncertain significance (Feb 17, 2024) | ||
11-120115348-T-C | not specified | Uncertain significance (Jan 12, 2024) | ||
11-120118240-G-C | not specified | Uncertain significance (Feb 28, 2024) | ||
11-120118246-C-T | not specified | Uncertain significance (Nov 11, 2024) | ||
11-120118249-T-C | not specified | Uncertain significance (May 09, 2023) | ||
11-120118306-C-T | not specified | Uncertain significance (Jun 18, 2021) | ||
11-120120593-T-C | not specified | Uncertain significance (Nov 27, 2023) | ||
11-120120597-A-C | not specified | Uncertain significance (Dec 21, 2022) | ||
11-120120606-G-C | not specified | Uncertain significance (Apr 05, 2023) | ||
11-120120626-C-G | not specified | Uncertain significance (Nov 07, 2024) | ||
11-120120627-G-A | not specified | Uncertain significance (Mar 04, 2025) | ||
11-120120638-G-A | not specified | Uncertain significance (Jan 10, 2022) | ||
11-120122986-A-G | not specified | Uncertain significance (Dec 22, 2024) | ||
11-120122995-G-A | not specified | Uncertain significance (Sep 26, 2023) | ||
11-120123016-A-C | not specified | Uncertain significance (May 02, 2023) | ||
11-120123025-G-A | not specified | Uncertain significance (Jun 25, 2024) | ||
11-120123044-G-A | not specified | Uncertain significance (Feb 24, 2025) | ||
11-120123049-T-G | not specified | Uncertain significance (Mar 03, 2022) | ||
11-120123055-C-T | not specified | Uncertain significance (Feb 15, 2023) | ||
11-120125683-G-T | Benign (Apr 19, 2018) | |||
11-120125723-C-G | not specified | Uncertain significance (Mar 25, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TRIM29 | protein_coding | protein_coding | ENST00000341846 | 9 | 74255 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
8.12e-8 | 0.910 | 125702 | 0 | 46 | 125748 | 0.000183 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.305 | 350 | 366 | 0.955 | 0.0000242 | 3868 |
Missense in Polyphen | 93 | 109.84 | 0.8467 | 1215 | ||
Synonymous | -0.458 | 166 | 159 | 1.05 | 0.0000114 | 1124 |
Loss of Function | 1.75 | 15 | 24.3 | 0.618 | 0.00000113 | 290 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000380 | 0.000380 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000164 | 0.000163 |
Finnish | 0.0000505 | 0.0000462 |
European (Non-Finnish) | 0.000186 | 0.000185 |
Middle Eastern | 0.000164 | 0.000163 |
South Asian | 0.000262 | 0.000261 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a crucial role in the regulation of macrophage activation in response to viral or bacterial infections within the respiratory tract. Mechanistically, TRIM29 interacts with IKBKG/NEMO in the lysosome where it induces its 'Lys-48' ubiquitination and subsequent degradation. In turn, the expression of type I interferons and the production of proinflammatory cytokines are inhibited. Additionally, induces the 'Lys-48' ubiquitination of TMEM173/STING in a similar way, leading to its degradation. {ECO:0000269|PubMed:27695001, ECO:0000269|PubMed:29038422}.;
- Pathway
- Hematopoietic Stem Cell Differentiation;Cytokine Signaling in Immune system;Immune System;EGFR1;Interferon gamma signaling;Interferon Signaling
(Consensus)
Recessive Scores
- pRec
- 0.117
Intolerance Scores
- loftool
- 0.628
- rvis_EVS
- -0.06
- rvis_percentile_EVS
- 48.84
Haploinsufficiency Scores
- pHI
- 0.509
- hipred
- N
- hipred_score
- 0.373
- ghis
- 0.577
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.945
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Trim29
- Phenotype
- homeostasis/metabolism phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan);
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;transcription by RNA polymerase II;innate immune response;cell-cell adhesion;negative regulation of protein localization to nucleus
- Cellular component
- lysosome;cell-cell adherens junction
- Molecular function
- p53 binding;DNA-binding transcription factor activity;protein binding;zinc ion binding;identical protein binding;cadherin binding involved in cell-cell adhesion